Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

Cited by (433)

Items 201–300 of 433

1. Seasonal effect on fatigue, pain and dryness in primary Sjögren’s syndrome
   Pierre‐Marie Duret, Nicolás Meyer, Alain Saraux, Valérie Devauchelle‐Pensec, Raphaèle Séror, Véronique Le Guern, C. Larroche, Aleth Perdriger, Jean Sibilia, Vianney Guardiolle et al. · 2020 · Arthritis Research & Therapy
2. Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
   Bayram Farisoğulları, Eduardo José Ferreira Santos, Emma K. Dures, Rinie Geenen, Pedro Machado · 2023 · RMD Open
3. Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology
   Xiao Li, Maierhaba Maitiyaer, Qing Tan, Wen Hui Huang, Yu Liu, Zhi Ping Liu, Yue Qiang Wen, Yu Zheng, Xing Chen, Rui Lin Chen et al. · 2024 · Frontiers in Pharmacology
4. Apport de l’échographie des glandes salivaires dans la prise en charge du syndrome de Sjögren : où en sommes-nous ?
   Divi Cornec, Valérie Devauchelle‐Pensec, Alain Saraux, Sandrine Jousse‐Joulin · 2015 · La Revue de Médecine Interne
5. A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials of Iguratimod Combined With Other Therapies for Sjogren’s Syndrome
   Liuting Zeng, Qi He, Kailin Yang, Wensa Hao, Ganpeng Yu, Hua Chen · 2022 · Frontiers in Immunology
6. Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development
   Foteini Karakontaki, Efstratios Panselinas, Vlasios Polychronopoulos, Athanasios G. Tzioufas · 2020 · Autoimmunity Reviews
7. An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development
   Soledad Retamozo, Antoni Sisó‐Almirall, Alejandra Flores-Chávez, Manuel Ramos‐Casals, Pilar Brito‐Zerón · 2021 · Expert Opinion on Pharmacotherapy
8. In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI
   Konstantina Delli, Erlin A. Haacke, Frans G. M. Kroese, Rodney Pollard, Stephan Ihrler, Bert van der Vegt, Arjan Vissink, Hendrika Bootsma, Frederik KL Spijkervet · 2016 · Annals of the Rheumatic Diseases
9. Sicca syndrome in systemic sclerosis: a narrative review on a neglected issue
   François Zimmermann, François Robin, Leïla Caillault, Claire Cazalets, Francisco Llamas‐Gutierrez, Ronan Garlantézec, Sandrine Jousse‐Joulin, Élisabeth Diot, Sami Eric Mensi, Nicolas Belhomme et al. · 2022 · Lara D. Veeken
10. Autoimmune diseases
    Sara Harsini, Nima Rezaei · 2023 · Elsevier eBooks
11. Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials
    Robert I. Fox, Carla M. Fox, Sara S. McCoy · 2023 · Expert Opinion on Emerging Drugs
12. Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling
    Taibiao Lyu, Hui Jiang, Liuting Zeng, Suying Liu, Chengmei He, Chaowen Luo, Qiao Lin, Yan Zhao, Hua Chen · 2023 · Arthritis Research & Therapy
13. Primary Sjögren’s syndrome: new perspectives on salivary gland epithelial cells
    Jiaqi Hou, Yiyi Feng, Zhixia Yang, Yimei Ding, Dandan Cheng, Zhonghao Shi, Rouxin Li, Luan Xue · 2024 · European journal of medical research
14. Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome
    Soledad Retamozo, Chiara Baldini, Hendrika Bootsma, Salvatore De Vita, Thomas Dörner, Benjamin A. Fisher, Jacques‐Eric Gottenberg, Gabriela Hernández‐Molina, Agnes Kocher, Belchin Kostov et al. · 2021 · Drugs & Aging
15. Sjögren’s syndrome: shedding light on emerging and key drug targets
    Dominic Ridgewell, Nishanthi Thalayasingam, Wan‐Fai Ng · 2022 · Expert Opinion on Therapeutic Targets
16. Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations
    Claudio Vitali, Marzia Dolcino, Nicoletta Del Papa, Antonina Minniti, Francesca Serena Pignataro, Wanda Maglione, Claudio Lunardi, Antonio Puccetti · 2019 · ACR Open Rheumatology
17. World Workshop on Oral Medicine VIII: Development of a core outcome set for dry mouth: a systematic review of outcome domains for xerostomia
    Paswach Wiriyakijja, Sven Eric Niklander, Alan Roger Santos‐Silva, Michal Kuten‐Shorrer, Melanie Louise Simms, Alessandro Villa, Vidya Sankar, Alexander Ross Kerr, Richeal Ní Ríordáin, Siri Beier Jensen et al. · 2023 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
18. Primary Sjögren's Syndrome Prevalence: What if Sjögren was Right After All? Comment on the Article by Maciel et al
    Gaëtane Nocturne, Raphaèle Séror, Xavier Mariette A, Valérie Devauchelle‐Pensec, Alain Saraux, Laurent Chiche · 2017 · Arthritis Care & Research
19. Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren’s Syndrome: Clues for a Personalized Medicine
    Luca Quartuccio, Ginevra De Marchi, Simone Longhino, Valeria Manfrè, Maria Teresa Rizzo, Saviana Gandolfo, Alberto Tommasini, Salvatore De Vita, Robert I. Fox · 2021 · Frontiers in Immunology
20. Sjögren‐Syndrom
    Fiona André, Barbara C. Böckle · 2022 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
21. Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group
    Yann Nguyen, Maxime Beydon, Nathan Foulquier, Rachael A. Gordon, Coralie Bouillot, Katherine M. Hammitt, Simon Bowman, Xavier Mariette A, Sara S. McCoy, Divi Cornec et al. · 2024 · Seminars in Arthritis and Rheumatism
22. Novel therapies in Sjögren’s disease: A systematic review of the literature
    Cristina Pelkas, Kyle B. Franke, Fabien B. Vincent, Maureen Rischmueller · 2025 · Best Practice & Research Clinical Rheumatology
23. Ultraschalldiagnostik beim Sjögren-Syndrom
    Valentin Sebastian Schäfer, Wolfgang Schmidt · 2017 · Zeitschrift für Rheumatologie
24. Disease activity and patient reported outcome measures in Sjögren’s – what are the best tools to evaluate?
    Raphaèle Séror, Saaeha Rauz, Marjolaine Gosset, Simon Bowman · 2019 · Lara D. Veeken
25. Peripheral Neuropathies Associated With Vasculitis and Autoimmune Connective Tissue Disease
    Chafic Karam · 2020 · CONTINUUM Lifelong Learning in Neurology
26. Novel and potential future therapeutic options in Sjögren's syndrome
    Ting Zhao, Runrun Zhang, Zhaofu Li, Dongdong Qin, Xinchang Wang · 2024 · Heliyon
27. Primary Sjögren's syndrome: new beginning for evidence-based trials
    Alain Saraux, Valérie Devauchelle‐Pensec · 2021 · The Lancet
28. Effectiveness of pharmacological interventions for Sjogren syndrome - A systematic review
    R. Choudhary, SS. Reddy, R. Nagaraju, Ravleen Nagi, P. Rathore, R. Sen · 2022 · Journal of Clinical and Experimental Dentistry
29. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren’s syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway
    Sabrina Lisi, Margherita Sisto, Massimo D’Amore, Dario Domenico Lofrumento · 2014 · International Immunology
30. New drugs for the treatment of dry eye disease
    William H. Ridder, Apoorva Karsolia · 2015 · Clinical Optometry
31. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren’s
    Carl Cooper, Samantha Wratten, Rebecca Williams‐Hall, ARTHUR A.M. BOOKMAN, Briana C. Ndife, Wolfgang Hueber, Pushpendra Goswami · 2022 · Rheumatology and Therapy
32. Profiles of peripheral B cell subsets in a cohort of primary Sjögren's syndrome patients and their potential clinical significance
    Yixiao Xing, Xiaotian Li, Wei Pan, Hong Hua · 2024 · Journal of Dental Sciences
33. Biologics in Sjögren's syndrome
    Charalampos Skarlis, Nikolaos Marketos, Clio P. Mavragani · 2019 · Pharmacological Research
34. Evaluation and management of dry mouth and its complications in rheumatology practice
    Zohreh Khavandgar, Blake M. Warner, Alan N. Baer · 2023 · Expert Review of Clinical Immunology
35. The utility of monitoring peripheral blood lymphocyte subsets by flow cytometric analysis in patients with rheumatological diseases treated with rituximab
    Jessica Alice Day, Vidya Sadanand Limaye, Susanna Proudman, John D. Hayball, Pravin Hissaria · 2017 · Autoimmunity Reviews
36. Biologic therapy in Sjögren’s syndrome
    Qin Shao · 2020 · Clinical Rheumatology
37. Selection of study endpoints and patients for clinical trials in primary Sjögren's syndrome
    Suzanne Arends, Liseth de Wolff, Liselotte Deroo, Gwenny M. P. J. Verstappen, Arjan Vissink, Frans G. M. Kroese, Dirk Sw Elewaut, Isabelle Peene, Hendrika Bootsma · 2022 · Clinical and Experimental Rheumatology
38. Efficacy and safety of rituximab in rheumatic diseases
    Eva Rath, Jochen Zwerina, Bastian Oppl, Valerie Nell-Duxneuner · 2015 · Wiener Medizinische Wochenschrift
39. Outcome Measures in Primary Sjögren’s Syndrome
    Raphaèle Séror, Simon Bowman · 2020 · Arthritis Care & Research
40. Depression is the most significant independent predictor of fatigue in patients with primary Sjögren’s syndrome
    Koray Ayar, Meliha Kasapoğlu Aksoy, Tülay Dilara Hattatoğlu, Büşra Yeşil · 2023 · Archives of Rheumatology
41. A review of the roles of exosomes in salivary gland diseases with an emphasis on primary Sjögren's syndrome
    Xianzhen Cui, Liu Liu, Chengchen Duan, Suning Mao, Guanru Wang, Honglin Li, Cheng Miao, Yubin Cao · 2024 · Journal of Dental Sciences
42. A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjögren Disease Randomized Controlled Trials
    Maxime Beydon, Yann Nguyen, Rachael A. Gordon, Nathan Foulquier, Coralie Bouillot, Katherine M. Hammitt, Simon Bowman, Xavier Mariette A, Divi Cornec, Sara S. McCoy et al. · 2025 · The Journal of Rheumatology
43. Unraveling the transcriptome-based network of tfh cells in primary sjogren syndrome: insights from a systems biology approach
    Danyang Luo, Lei Li, Yi Yang, Yulin Ye, Jiawei Hu, Yuan Zong, Jiawen Zhao, Yiming Gao, Haimin Xu, Ning Li et al. · 2023 · Frontiers in Immunology
44. Recomendaciones SER sobre la utilización de fármacos biológicos en el síndrome de Sjögren primario
    José Luís Andreu, Mónica Fernández Castro, Petra Díaz del Campo Fontecha, Hèctor Corominas, Javier Narváez, José Carlos Rosas Gómez de Salazar, Íñigo Rúa‐Figueroa, Miguel Ángel Abad Hernández, María Noelia Álvarez Rivas, Javier del Pino Montes et al. · 2019 · Reumatología Clínica
45. Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren’s syndrome
    Xiao Zheng, Jiaoyang Di, Xuexiao Chen, Fang Li, Yixuan Liu, Jingjing Cao, Xiaoran Ning, Lin Wei, Guimin Zheng · 2025 · Frontiers in Immunology
46. Salivary Gland Disorders and Diseases
    Siri Beier Jensen, Arjan Vissink, Norman A. Firth · 2019 · Springer eBooks
47. New biological therapies in Sjögren's syndrome
    Gaëtane Nocturne, Divi Cornec, Raphaèle Séror, Xavier Mariette · 2015 · Best Practice & Research Clinical Rheumatology
48. Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
    Lam Phung, Ivonne V. Lollett, Raquel Goldhardt, Janet L. Davis, Larry M. Young, Dana P. Ascherman, Anat Galor · 2017 · American Journal of Ophthalmology Case Reports
49. Ocular Involvement in Sjögren’s Syndrome: Advances in Therapy
    John A. Gonzales, Thomas M. Lietman · 2018 · Current Treatment Options in Rheumatology
50. Effectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjögren’s Syndrome: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
    Ben Li, Jiaqi Hou, Yue Yang, Xuemei Piao, Yueying Chen, Luan Xue, Dan Wang, Jiandong Hu, LI Guo-ling, Xiangxiang Wu et al. · 2017 · Evidence-based Complementary and Alternative Medicine
51. Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome
    Sophanit Pepple, Jack Arnold, Edward M J Vital, Andy C. Rawstron, Colin Thomas Pease, Shouvik Dass, Paul Emery, Md Yuzaiful Md Yusof · 2022 · ACR Open Rheumatology
52. Insights into future management of lupus nephritis
    Anca Askanase, Maria Dall’Era, Salem J. Almaani · 2024 · Frontiers in Lupus
53. Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren’s disease
    Liseth de Wolff, Gwenny M. P. J. Verstappen, Alja J. Stel, Greetje S. van Zuiden, Jolien F. van Nimwegen, Arjan Vissink, Frans G. M. Kroese, Suzanne Arends, Hendrika Bootsma · 2025 · RMD Open
54. Efficacy of early rituximab treatment in primary Sjögren’s syndrome: a systematic review and meta-analysis
    Mohammad Shahdadian, Mohammad Ali Saghiri, Eugenio Capitle · 2025 · Journal of Rheumatic Diseases
55. Common pathological mechanisms and therapeutic strategies in primary Sjogren’s syndrome and primary biliary cholangitis: from tissue immune microenvironment to targeted therapy
    Keying Ye, Xinyi Yao, Dingqi Lu, Chenfei Tan, Xinchang Wang · 2025 · Frontiers in Immunology
56. Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center
    Onorina Berardicurti, Viktoriya Pavlych, Ilenia Di Cola, Piero Ruscitti, Paola Di Benedetto, Luca Navarini, Annalisa Marino, Paola Cipriani, Roberto Giacomelli · 2021 · The Journal of Rheumatology
57. Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022
    Wenpeng Song, Hao Wang, Xiaoyan Wang · 2023 · Heliyon
58. Challenges in Treatment of Primary Sjögren’s Syndrome and Opportunities for Chinese Medicine
    Jiaqi Hou, Luan Xue · 2019 · Chinese Journal of Integrative Medicine
59. Pediatric Sjogren syndrome with distal renal tubular acidosis and autoimmune hypothyroidism: an uncommon association
    Amit Agarwal, Pradeep Kumar, Nomeeta Gupta · 2015 · CEN Case Reports
60. Classification criteria and treatment modalities in primary Sjögren’s syndrome
    Alia Fazaa, Tristan Bourcier, Emmanuel Chatelus, Christelle Sordet, Arnaud Theulin, Jean Sibilia, Jacques‐Eric Gottenberg · 2014 · Expert Review of Clinical Immunology
61. Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren's Syndrome: A Retrospective Analysis in a Real-Life Setting
    Viktoriya Pavlych, Claudia Di Muzio, Alessia Alunno, Francesco Carubbi · 2020 · Frontiers in Medicine
62. Sjögren's Syndrome
    E. William St. Clair, Victoria D. Lackey · 2016 · Elsevier eBooks
63. Treatment of Primary Sjögren Syndrome With Rituximab
    Denise Louise Faustman, Frederick B. Vivino, Steven E. Carsons · 2014 · Annals of Internal Medicine
64. Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatment
    Zhi Feng Sherman Lim, Alberta Yik-Bun Hoi, Fabien B. Vincent, Joshua Daniel Ooi, Eric Francis Morand, Maureen Rischmueller, Yi Tian Ting · 2025 · Journal of Translational Autoimmunity
65. Pulmonary Manifestations of Sjögren's Disease
    Louise Byrne, Cormac McCarthy, Aurélie Fabre, Nishant Gupta · 2024 · Seminars in Respiratory and Critical Care Medicine
66. Mycophenolate for the treatment of primary Sjögren’s syndrome
    Weiqian Chen, Jin Lin · 2020 · Journal of Translational Internal Medicine
67. Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sjögren syndrome
    Lauren Skudalski, Neda Shahriari, Kristin M. Torre, Sueheidi Santiago, Lorin A. Bibb, Vijay Kodomudi, Jane Margaret Grant-Kels, Jun Lu · 2022 · Journal of the American Academy of Dermatology
68. Melatonin: a potential therapeutic approach for the management of primary Sjögren’s syndrome
    Yi Liu, Ya‐Qin Tan, Gang Zhou · 2023 · Immunologic Research
69. Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
    Alexandre Dumusc, Fahad Alromaih, Matthieu Perreau, Thomas Hügle, Pascal Zufferey, Diana Dan · 2023 · Arthritis Research & Therapy
70. Sjögren's and plasma cell variant Castleman disease: a case report
    Yvonne Dei‐Adomakoh, Leslie Quarcoopome, Afua O.D. Abrahams, Catherine Idara Segbefia, Dzifa Ida Dey · 2018 · Ghana Medical Journal
71. Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren’s disease
    Baptiste Chevet, Valérie Devauchelle‐Pensec, Elena Pontarini, Valentin M. D. Baloche, Michele Bombardieri, Simon Bowman, Michael Barnes, Antoine G. Sreih, Jinqi Liu, Sheila Kelly et al. · 2025 · Annals of the Rheumatic Diseases
72. Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome
    Nicoletta Del Papa, Antonina Minniti, Wanda Maglione, Francesca Serena Pignataro, Roberto Felice Caporali, Claudio Vitali · 2021 · Biomolecules
73. Diagnostic utility of a second minor salivary gland biopsy in patients with suspected Sjögren's syndrome: A retrospective cohort study
    Guillermo Carvajal Alegria, Thibaud Depinoy, Valérie Devauchelle‐Pensec, Sandrine Jousse‐Joulin, Thierry Marhadour, Dewi Guellec, Pascale Marcorelles, Jacques‐Olivier Pers, Alain Saraux, Divi Cornec · 2022 · Joint Bone Spine
74. Treatment of non-systemic Sjögren's syndrome: Potential prevention of systematization with immunosuppressant agent/biotherapy
    Aude Belbézier, Thi Thu Thuy Nguyen, Mélanie Arnaud, B. Ducotterd, Marie Vangout, Alban Deroux, Catherine Mansard, F. Sarrot-Reynauld, Laurence Bouillet · 2024 · Journal of Translational Autoimmunity
75. Expert Perspective: Challenges in Sjögren's Disease
    Gaëtane Nocturne, Xavier Mariette A · 2023 · Arthritis & Rheumatology
76. Review of Sjögren’s Syndrome for Primary Physicians
    Seung‐Ki Kwok · 2015 · Korean Journal of Medicine
77. Le syndrome de Gougerot-Sjögren primitif : une actualisation
    Pierre Youinou, Jacques‐Olivier Pers · 2016 · Revue du Rhumatisme
78. Connecting salivary gland inflammation to specific symptoms in Sjögren’s disease
    Niels Sluijpers, Sarah A. Pringle, Hendrika Bootsma, Fred K. L. Spijkervet, Arjan Vissink, Konstantina Delli · 2024 · Expert Review of Clinical Immunology
79. Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How
    Joyce J. B. C. van Beers, Jan G.M.C. Damoiseaux · 2021 · Biomolecules
80. Seronegative Sicca Syndrome: Diagnostic Considerations and Management Strategies
    Yordanka Mincheva Basheva-Kraeva, Krasimir Iliev Kraev, Petar Angelov Uchikov, Maria Ilieva Kraeva, Bozhidar Krasimirov Hristov, Nina Staneva Stoyanova, Vesela Todorova Mitkova-Hristova, Borislav Ivanov, Stanislav S. Karamitev, Nina Koleva et al. · 2025 · Life
81. Biologic Therapy in the Treatment of Sjögren’s Syndrome: a Clinical Perspective
    Chadwick R. Johr, Frederick B. Vivino · 2018 · Current Treatment Options in Rheumatology
82. Recommendations for the treatment of Sjögren's syndrome
    Valéria Valim, Virgínia Fernandes Moça Trevisani, Sandra Gofinet Pasoto, Érica Vieira Serrano, Sandra Lúcia Euzébio Ribeiro, Tania Fidelix, Verônica Silva Vilela, Leandro Lara do Prado, Leandro Augusto Tanure, Tatiana Nayara Libório‐Kimura et al. · 2015 · Revista Brasileira de Reumatologia (English Edition)
83. Targeting EZH2 prevents the occurrence and mitigates the development of Sjögren's syndrome in mice
    Shicong Zhu, Mei Liu, Fenglin Zhu, Xi Yu, Junsong Wen, Chengyin Li · 2022 · International Immunopharmacology
84. Future treatments for Sjögren's syndrome
    Jacques‐Olivier Pers, Alain Saraux · 2016 · La Presse Médicale
85. Stratifying primary Sjögren’s syndrome: killers in the balance?
    Simon Bowman, Benjamin A. Fisher · 2015 · Arthritis Research & Therapy
86. Can We Expect Any Effect of Rituximab on Fatigue in Primary Sjögren Syndrome?: A Systematic Review and Critical Appraisal.
    An-Marie Hermans, Jean‐Baptiste Vulsteke, Jan Lenaerts, Ellen De Langhe · 2021 · PubMed
87. Efficacy and safety of iguratimod in patients with primary Sjögren’s syndrome: a multicentre randomised controlled trial
    Xiaochan Chen, Ting Zhang, Lifeng Meng, Cheng Xu, Lichun Jiang, Guofang Wang, Tao Hou, Hongzhi Wang, Yongmei Han, Ying Guan et al. · 2025 · RMD Open
88. Improvement of constrictive bronchiolitis (bronchiolitis obliterans) after rituximab therapy in 2 patients with primary sjögren syndrome
    Kirill Lipatov, Aahd F. Kubbara, Laura E. Weerheim, Dante N. Schiavo, Ulrich Specks, Jay Hoon Ryu, Misbah Baqir · 2021 · Respiratory Medicine Case Reports
89. What is the best strategy in treating catastrophic antiphospholipid syndrome?
    Ignasi Rodríguez‐Pintó, Irene Santacreu, Ricard Cervera, Gerard Espinosa · 2015 · International Journal of Clinical Rheumatology
90. Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease
    Ali Akgül, Christian Furlan Freguia, Massimo Maddaloni, Carol A. Hoffman, Alexandria Voigt, Cuong Quoc Nguyen, Neil A. Fanger, Gary R. Fanger, David W. Pascual · 2023 · Scientific Reports
91. Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease
    Cheïma Boudjeniba, Perrine Soret, Diana Trutschel, Antoine Hamon, Valentin M. D. Baloche, Bastien Chassagnol, Emiko Desvaux, Antoine Bichat, Audrey Aussy, Philippe E. Moingeon et al. · 2024 · Clinical Immunology
92. Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study
    Alice Tison, Sandrine Jousse‐Joulin, Maëlys Consigny, Philipp Moog, Benedikt Gabriel Hofauer, Eric HACHULLA, Christophe Lamotte, Jacques Morel, Gaël Mouterde, Vera Milić et al. · 2024 · Lara D. Veeken
93. Salivary Gland Disorders and Diseases
    Siri Beier Jensen, Arjan Vissink, Norman A. Firth · 2017 · Springer eBooks
94. Sjögren’s Syndrome as an Ocular Problem: Signs and Symptoms, Diagnosis, Treatment
    Dorota Kopacz, Piotr Maciejewicz · 2019 · IntechOpen eBooks
95. Use of Rituximab in the Management of Sjögren’s Syndrome
    Francesco Carubbi, Alessia Alunno, Paola Cipriani, Onorina Berardicurti, Piero Ruscitti, Vasiliki Liakouli, Francesco Ciccia, G Triolo, Roberto Gerli, Roberto Giacomelli · 2015 · Current Treatment Options in Rheumatology
96. Pharmacotherapy for managing extraglandular symptoms of primary Sjögren’s syndrome
    Gwenny M. P. J. Verstappen, Frans G. M. Kroese, Arjan Vissink, Hendrika Bootsma · 2015 · Expert Opinion on Orphan Drugs
97. Conduite à tenir devant une sécheresse buccale
    Sylvie Boisramé, Matthieu Remaud, Jacques‐Olivier Pers · 2016 · HAL
98. Sleep apnea in Sjögren’s syndrome potentially influences the EULAR Sjögren’s syndrome patient reported index
    Maike Jülich, Stephan Budweiser, Jan Thoden, Reinhard Edmund Voll, Florian Kollert · 2018 · Modern Rheumatology
99. B-Zell-Therapie mit Rituximab bei rheumatoider Arthritis
    Marc Schmalzing, Hans‐Peter Tony · 2015 · Zeitschrift für Rheumatologie
100. SER recommendations on the use of biological drugs in primary Sjögren's syndrome
     José Luís Andreu, Mónica Fernández Castro, Petra Díaz del Campo Fontecha, Hèctor Corominas, Francisco Javier Narváez García, José Carlos Rosas Gómez de Salazar, Íñigo Rúa‐Figueroa, Miguel Ángel Abad Hernández, María Noelia Álvarez Rivas, Javier del Pino Montes et al. · 2019 · Reumatología Clínica (English Edition)